STOCKTON, CALIFORNIA/December 24, 2012 / Newswire/ -- Viratech Corp. (OTC: VIRA), the first open source biotech research social network platform, and Cancer.im, Inc. announced today that Cancer.im, Inc. has appointed Rachel Boulds as its Chief Financial Officer.
From August 2009 to the present, Ms. Boulds has been engaged in her sole accounting practice, preparing full disclosure financial statements for public companies to comply with GAAP and SEC requirements.
Since February 3, 2012, she has served as CFO of Independent Film Development Corporation. From August 2004 through July 2009, she was employed as an Audit Senior for HJ& Associates, LLC, where she performed audits and reviews for public and private companies, prepared financial statements to comply with GAAP and SEC requirements, performed analytical procedures and substantive testing for all financial statement accounts, researched, resolved and communicated technical accounting issues, and formulated management recommendations for process and internal control improvements. From 2003 through 2004, Ms. Boulds was employed as Audit Senior for Mohler, Nixon and Williams, planning and performing audits, reviews and compilations, preparing form 550 for filing with the Dept. of Labor, reviewing policies and operating procedures of a company’s benefit plan to recommend improvement of operations and insure compliance with the Department of Labor’s rules and regulations, prepared financial statements to comply with reporting and disclosure requirements under ERISA, performed analytical procedures and substantive testing for all financial statement accounts, researched, resolved and communicated technical accounting issues, formulated management recommendations for process and internal control improvements, worked closely with third party administrators to coordinate the receipt of necessary information in order to perform audits in a timely manner and meet filing deadlines, and supervised and trained new staff. From September 2001 through July 2003, Ms. Boulds worked as an ABAS Associate for PriceWaterhouseCoopers, providing auditing services to public and private companies, performing analysis and substantive testing on balance sheets and income and expense statement components, reviewed client’s revenue recognition policies to see that they were in compliance with relevant accounting standards, reviewed and documented clients’ internal control policies and procedures and made recommendations for improvements, supervised and coached new associates, assisted in preparing full disclosure financial statements, provided clients with adjusting journal entries and recommendations to improve procedures, and worked with clients to maximize engagement efficiency and meet reporting deadlines. From April 2000 through February 2001, she was employed as an eCommerce Accountant for the Walt Disney Group’s GO.com.
“I am very excited to be working with Cancer.im and Viratech, and to be a part of seeking new solutions for the treatment, care and management of cancer patients,” states Ms. Boulds.
About Cancer.im
Cancer.im, Inc. owns and operates http://cancer.im, a social network resource site for cancer patients, survivors, advocates, and volunteers. Cancer.im harnesses social collaboration utilities to develop what Viratech believes will become the first experience-based search engine powered by social collaboration. The site is scheduled to go from beta testing to full use on February 15, 2013. To learn more about the vision and potential of Cancer.im, see the explanatory video at http://www.youtube.com/watch?v=dz1tHRb3wvU&feature=youtu.be
or visit the site at http://cancer.im
About Viratech Corp.
Based in Stockton, California, Viratech Corp. has created an open source biotech research and development platform. Viratech has created a unique platform leveraging the utility of social collaboration, which will allow cancer research the opportunity for the first time to become open-sourced. This will be accomplished by allowing our development partners the ability to protect, promote and produce their research in unified online collaboration hubs known as micro-social networks. Viratech’s open source platform has integrated several intellectual property tools which, by leveraging our social collaboration network, can give our development partners a new intellectual property mechanism, which will help in addressing the protection of Intellectual Property, promotion through collaboration in our protected open source platform, and commercial development of the products achieved through collaborative research.
Using this platform, Viratech members can protect their intellectual property, then use Viratech’s micro-social network as a utility to promote and crowdfund the research and development to produce the new technology.
Forward-Looking Statements:
This press release includes forward-looking statements concerning the future performance of our business, its operations and its financial performance and condition, and also includes selected operating results presented without the context of accompanying financial results. These forward-looking statements include, among others, statements with respect to our objectives and strategies to achieve those objectives, as well as statements with respect to our beliefs, plans, expectations, anticipations, estimates or intentions. These forward-looking statements are based on our current expectations. We caution that all forward-looking information is inherently uncertain and actual results may differ materially from the assumptions, estimates or expectations reflected or contained in the forward-looking information, and that actual future performance will be affected by a number of factors, including economic conditions, technological change, regulatory change and competitive factors, many of which are beyond our control. Therefore, future events and results may vary significantly from what we currently foresee. We are under no obligation (and we expressly disclaim any such obligation) to update or alter the forward-looking statements whether as a result of new information, future events or otherwise.
Contact: Dr. Kevin Buckman
Viratech, Corp.
http://viratech.org
Email Contact: info@viratech.org
Newswire.net
Source: EmailWire.Com 
Source: EmailWire.com
